Corticosteroids combined with infliximab vs. corticosteroids sequential infliximab for acute severe ulcerative colitis with mucosal deficiency: a retrospective study
CS combined with IFX as first-line therapy may be an effective induction strategy in patients with ASUC with mucosal deficiency. Further large-scale, multicenter prospective studies are needed.
Authors
- Yongquan Shi (ORCID: https://orcid.org/0000-0001-9515-7577)
- Min Chen (ORCID: https://orcid.org/0000-0001-8248-5408)
- Jun Liu (ORCID: https://orcid.org/0000-0001-8300-8646)
- Xiaolei Liu (ORCID: https://orcid.org/0000-0002-6307-4475)
- Xiaojing Zhu (ORCID: https://orcid.org/0000-0002-2212-4077)
- Xianmin Xue
Institutions
- National Clinical Research Center for Digestive Diseases (CN)
- Xijing Hospital (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2024-11-20
- DOI
- https://doi.org/10.3389/fmed.2024.1442519
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China